
15 Sep 2026
Hello Patient buys Converse Health to extend AI agents past the front desk
Hello Patient said it acquired Converse Health, an AI workflow automation company for outpatient practices. The deal is meant to extend Hello Patient’s AI agents from front-office patient conversations into back-office work like reading referrals, tracking follow-ups, and assembling payer paperwork. Converse Health had raised $1.3 million; acquisition terms were not disclosed.
Same-day HEALTH primary that a patient-comms AI company bought a back-office outpatient automation firm, showing clinics bundling agentic AI across the full visit admin chain — from the first call through referrals, follow-ups, and payer paperwork.
Hello Patient positioning, as the company tells it: agentic AI for patient communications from the front office to the back office. Agentic AI here means software that can take multi-step actions, not only chat. File that picture as Hello Patient’s. This desk did not sit on a clinic phone line.
Converse Health, still company: an AI workflow automation company for outpatient medical practices — clinics that treat people without an overnight hospital stay. Founded in 2023 by Louis Sallerson, Val Zinchenko, and Adam Teitelman. The company says it raised $1.3 million and grew to serve dozens of practices in dermatology, women’s health, pain medicine, and orthopedics. File the 2023 founding, the three named founders, the $1.3 million, and those specialties as Converse Health’s via Hello Patient. This desk did not count the practices or see a cap table.
What Converse adds, as Hello Patient tells it: AI agents that read incoming referrals, track follow-up, and assemble payer paperwork — the insurance and billing forms a clinic sends so a visit can be covered. The company also says Converse handles document and chart work around a visit, and provides an AI layer that reads and writes to EHRs. An EHR is an electronic health record, the digital patient chart. A referral is one clinician sending a patient to another. File that back-office stack as the company’s. This desk did not watch an agent open a fax or write into a chart.
Target customers, still company: high-volume outpatient settings — primary care, urgent care, ENT, dental, and specialty practices. File that customer list as Hello Patient’s. This desk did not audit a client roster.
Problem framing, company — attribute, do not independently certify: up to 42% of patient calls and texts go unanswered during busy hours; a referral often arrives as a fax someone must open, classify, match to a patient, and file; staff then play phone tag with patients, referring offices, and payers. File the 42% line and that fax / phone-tag picture as Hello Patient’s. This desk did not count unanswered calls.
Named customer voice on the same wire: Jeff Craven, chief operating officer at Ortho1. Hello Patient says the orthopedic group is running this back-office technology across 100% of incoming referrals, successfully scheduling 57% of engaged patients, and processing referrals in half the time. File the name, title, and those three figures as company/customer claims. This desk did not review Ortho1’s referral log. The quoted color stays in Sources.
Named company voice: Alex Cohen, chief executive and founder of Hello Patient. He argues practices want workflows and decision-making redesigned around AI agents, rather than bolting a tool onto one task at a time. File the name and title as the company’s. His quotes are color only and stay in Sources.
Plain English for the rest of the card: agentic AI = software that can take multi-step actions, not only chat. EHR = electronic health record, the digital patient chart. Payer paperwork = insurance and admin forms for coverage and billing. Referral = one clinician sending a patient to another. Outpatient = care that does not include an overnight hospital stay.
PRIMARY here: Hello Patient’s 15 Sep 2026 PR Newswire company release — Tier A company source, the original record. The company site is product-home context, not a second originating newsroom. The acquisition, the Austin / agentic-patient-comms positioning, the Converse 2023 founders and $1.3 million raise, the referral / follow-up / payer-paperwork / EHR read-write pitch, the high-volume outpatient customer list, the 42% unanswered-call line, the Ortho1 100% / 57% / half-the-time figures, and the Cohen name are company-attributed. Capability claims, the 42% line, and the Ortho1 stats stay company-attributed. NOT claimed: a purchase price, a valuation, that agents do “the majority of work” as an independent fact, independently verified unanswered-call or referral rates, that this desk tested the agents or reviewed a purchase agreement, a stock tip, or investment advice. Distinct from the already-filed evvy-40m-series-b, mithrl-20m-series-a, powerful-medical-queen-of-hearts-fda-de-novo, azmed-azchest-fda-6th, unc-openai-foundation-40m-cancer-vaccines, nvidia-chop-cardiac-monai, curvebeam-ai-fda-ct-bmd-510k, nara-health-14m, tandem-health-100m-series-b, and oracle-health-clinical-ai-agent-nurses.
RELATED
- Evvy raises $40M Series B to scale AI women’s health diagnostics
- Nara Health raises $14M for AI-native health-insurance administration
- Tandem Health raises $100M Series B to build an AI clinic OS for Europe
- Oracle Health Clinical AI Agent ships for U.S. nurses to cut charting and speed care
- FDA clears Powerful Medical’s Queen of Hearts AI for urgent ECG heart-attack flags
- UNC Lineberger gets $40M from OpenAI Foundation for cancer-vaccine AI data
- CurveBeam AI wins FDA 510(k) for CT-based bone density measurement
- CHOP uses open-source NVIDIA AI to model kids’ hearts in seconds
- AZmed wins 6th FDA clearance, expanding AZchest on chest X-rays
- Mithrl raises $20M Series A for biopharma AI infrastructure
On 15 Sep 2026, Austin-based Hello Patient announced it had acquired Converse Health. The company PRIMARY via PR Newswire, dated September 15, 2026, 09:00 ET, and datelined AUSTIN, Texas, is the filing event. These are company claims. This desk did not see a purchase agreement. Terms were not disclosed.